Interaction Checker

Interaksi Sefoksitin

Sefoksitin (Mefoxin), golongan sefalosporin, memiliki 63 interaksi terdokumentasi dalam label FDA dan lembar fakta yang kami indeks: 27 mayor, 35 moderat, 1 minor, dan 0 dengan label yang melaporkan tidak ada interaksi bermakna. Setiap entri di bawah ini mengutip kalimat yang mendasarinya. Halaman obat ini adalah titik awal, bukan putusan untuk situasi Anda.

Interaksi dari label

Interaksi mayor (27)

  • Amoksisilinantibiotik penisilinMayor

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (label Sefoksitin, Kontraindikasi)

  • Amoksisilin dan klavulanatantibiotik penisilinMayor

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (label Sefoksitin, Kontraindikasi)

  • Ampisilinantibiotik penisilinMayor

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (label Sefoksitin, Kontraindikasi)

  • Ampisilin dan sulbaktamantibiotik penisilinMayor

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (label Sefoksitin, Kontraindikasi)

  • Benzilpenisilin (penisilin G)antibiotik penisilinMayor

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (label Sefoksitin, Kontraindikasi)

  • Dikloksasilinantibiotik penisilinMayor

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (label Sefoksitin, Kontraindikasi)

  • ErtapenemantibiotikMayor

    INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (label Ertapenem, Kontraindikasi)

  • Fenoksimetilpenisilin (penisilin V)antibiotik penisilinMayor

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (label Sefoksitin, Kontraindikasi)

  • Imipenem dan silastatinantibiotikMayor

    Hypersensitivity Reactions: Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving therapy with beta-lactams. (label Imipenem dan silastatin, Peringatan dan perhatian)

  • Nafsilinantibiotik penisilinMayor

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (label Sefoksitin, Kontraindikasi)

  • Oksasilinantibiotik penisilinMayor

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (label Sefoksitin, Kontraindikasi)

  • Piperasilin dan tazobaktamantibiotik penisilinMayor

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (label Sefoksitin, Kontraindikasi)

  • SefadroksilsefalosporinMayor

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (label Sefoksitin, Kontraindikasi)

  • SefaklorsefalosporinMayor

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (label Sefoksitin, Kontraindikasi)

  • SefaleksinsefalosporinMayor

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (label Sefoksitin, Kontraindikasi)

  • SefazolinsefalosporinMayor

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (label Sefoksitin, Kontraindikasi)

  • SefdinirsefalosporinMayor

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (label Sefoksitin, Kontraindikasi)

  • SefepimsefalosporinMayor

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (label Sefoksitin, Kontraindikasi)

  • SefiksimsefalosporinMayor

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (label Sefoksitin, Kontraindikasi)

  • SefotaksimsefalosporinMayor

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (label Sefoksitin, Kontraindikasi)

  • SefotetansefalosporinMayor

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (label Sefoksitin, Kontraindikasi)

  • SefpodoksimsefalosporinMayor

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (label Sefoksitin, Kontraindikasi)

  • SefprozilsefalosporinMayor

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (label Sefoksitin, Kontraindikasi)

  • SeftarolinsefalosporinMayor

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (label Sefoksitin, Kontraindikasi)

  • SeftazidimsefalosporinMayor

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (label Sefoksitin, Kontraindikasi)

  • SeftriaksonsefalosporinMayor

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (label Sefoksitin, Kontraindikasi)

  • SefuroksimsefalosporinMayor

    Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (label Sefoksitin, Kontraindikasi)

Interaksi moderat (35)

  • AmikasinaminoglikosidaModerat

    Aminoglycosides: Increased potential of nephrotoxicity. (label Sefoksitin, Interaksi obat)

  • Asam etakrinatdiuretik loopModerat

    Ethacrynic acid may increase the ototoxic potential of other drugs such as aminoglycoside and some cephalosporin antibiotics. (label Asam etakrinat, Interaksi obat)

  • Azelastin dan flutikasonantihistaminModerat

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (label Sefoksitin, Peringatan dan perhatian)

  • AztreonamantibiotikModerat

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (label Aztreonam, Peringatan dan perhatian)

  • BeklometasonkortikosteroidModerat

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (label Sefoksitin, Peringatan dan perhatian)

  • BetametasonkortikosteroidModerat

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (label Sefoksitin, Peringatan dan perhatian)

  • BudesonidkortikosteroidModerat

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (label Sefoksitin, Peringatan dan perhatian)

  • Budesonid dan formoterolkortikosteroidModerat

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (label Sefoksitin, Peringatan dan perhatian)

  • DeflazakortkortikosteroidModerat

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (label Sefoksitin, Peringatan dan perhatian)

  • DeksametasonkortikosteroidModerat

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (label Sefoksitin, Peringatan dan perhatian)

  • DesonidkortikosteroidModerat

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (label Sefoksitin, Peringatan dan perhatian)

  • FludrokortisonkortikosteroidModerat

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (label Sefoksitin, Peringatan dan perhatian)

  • FlunisolidkortikosteroidModerat

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (label Sefoksitin, Peringatan dan perhatian)

  • FluosinonidkortikosteroidModerat

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (label Sefoksitin, Peringatan dan perhatian)

  • FlutikasonkortikosteroidModerat

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (label Sefoksitin, Peringatan dan perhatian)

  • Flutikason dan salmeterolkortikosteroidModerat

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (label Sefoksitin, Peringatan dan perhatian)

  • Furosemiddiuretik loopModerat

    Cephalosporin Furosemide can increase the risk of cephalosporin-induced nephrotoxicity even in the setting of minor or transient renal impairment. (label Furosemid, Interaksi obat)

  • GentamisinaminoglikosidaModerat

    Aminoglycosides: Increased potential of nephrotoxicity. (label Sefoksitin, Interaksi obat)

  • HalobetasolkortikosteroidModerat

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (label Sefoksitin, Peringatan dan perhatian)

  • HidrokortisonkortikosteroidModerat

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (label Sefoksitin, Peringatan dan perhatian)

  • KlobetasolkortikosteroidModerat

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (label Sefoksitin, Peringatan dan perhatian)

  • MetilprednisolonkortikosteroidModerat

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (label Sefoksitin, Peringatan dan perhatian)

  • MikofenolatimunosupresanModerat

    Examples Cyclosporine A, trimethoprim/sulfamethoxazole, bile acid sequestrants (cholestyramine), rifampin as well as aminoglycoside, cephalosporin, fluoroquinolone and penicillin classes of antimicrobials Drugs Modulating Glucuronidation Clinical Impact Concomitant use with drugs inducing glucuronidation decreases MPA systemic exposure, potentially reducing mycophenolate… (label Mikofenolat, Interaksi obat)

  • MometasonkortikosteroidModerat

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (label Sefoksitin, Peringatan dan perhatian)

  • NeomisinaminoglikosidaModerat

    Aminoglycosides: Increased potential of nephrotoxicity. (label Sefoksitin, Interaksi obat)

  • Olopatadin dan mometasonantihistaminModerat

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (label Sefoksitin, Peringatan dan perhatian)

  • PlazomisinaminoglikosidaModerat

    Aminoglycosides: Increased potential of nephrotoxicity. (label Sefoksitin, Interaksi obat)

  • PrednisolonkortikosteroidModerat

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (label Sefoksitin, Peringatan dan perhatian)

  • PrednisonkortikosteroidModerat

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (label Sefoksitin, Peringatan dan perhatian)

  • ProbenesidModerat

    Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (label Probenesid, Interaksi obat)

  • Probenesid dan kolkisinModerat

    DRUG INTERACTIONS When probenecid is used to elevate plasma concentrations of penicillin, or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (label Probenesid dan kolkisin, Interaksi obat)

  • ProtaminModerat

    Drug Interactions Protamine sulfate has been shown to be incompatible with certain antibiotics, including several of the cephalosporins and penicillins (see DOSAGE AND ADMINISTRATION ). (label Protamin, Perhatian)

  • SiklesonidkortikosteroidModerat

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (label Sefoksitin, Peringatan dan perhatian)

  • TobramisinaminoglikosidaModerat

    Aminoglycosides: Increased potential of nephrotoxicity. (label Sefoksitin, Interaksi obat)

  • TriamsinolonkortikosteroidModerat

    High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (label Sefoksitin, Peringatan dan perhatian)

Penyebutan minor (1)

  • MeropenemantibiotikMinor

    Before initiating therapy with Meropenem for injection, it is important to inquire about previous hypersensitivity reactions to penicillins, cephalosporins, other β-lactams, and other allergens. (label Meropenem, Peringatan dan perhatian)

Periksa Sefoksitin terhadap semua yang Anda gunakan. Tambahkan seluruh daftar Anda; setiap pasangan diperiksa sekaligus.

Buka di pemeriksa

Bukan nasihat medis. Tingkat keparahan mencerminkan kata-kata dalam label, bukan keadaan Anda. Tanda “mayor” bisa merupakan hal yang rutin di bawah pengawasan, dan tanda “minor” bisa menjadi penting pada dosis tinggi. Tanyakan kepada apoteker.